| Name | endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
| Description | Predicted to enable BMP receptor binding activity. Predicted to be involved in negative regulation of nervous system development; positive regulation of BMP signaling pathway; and positive regulation of epidermis development. Predicted to be located in plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ELAPOR2 (also referred to as EIG121‐like or EIG121L) is an evolutionarily conserved transmembrane protein that has emerged as a regulator of cellular differentiation processes. Studies in Xenopus embryos have shown that ELAPOR2 is robustly expressed in the ventral ectoderm early in development, where it localizes to regions fated for epidermal differentiation. Functional experiments demonstrated that loss of ELAPOR2 severely impairs epidermal differentiation by markedly suppressing BMP/Smad1 signaling, a pathway essential for driving the epidermal fate. In these contexts, ELAPOR2 appears to physically interact with BMP receptors, thereby acting as a positive modulator of BMP pathway activation (1,2)."}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition, evidence from studies in human pathology suggests that aberrant regulation of ELAPOR2 may contribute to disease-related alterations in cellular identity. For instance, in mesenchymal stem cells isolated from patients with psoriasis, increased expression of ELAPOR2 accompanies other changes that could facilitate T lymphocyte activation by affecting DMSC proliferation. This observation implies that ELAPOR2 might also function as a mediator of cell differentiation and tissue homeostasis in the skin (3).\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Together, these observations support the view that ELAPOR2 is a critical regulator of differentiation signaling pathways—most notably through modulation of BMP receptor activity—and underscore its potential role in both normal developmental processes and disease states characterized by disrupted cellular identity.\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n (1)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", \n (2)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", \n (3)."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tetsuro Araki, Morioh Kusakabe, Eisuke Nishida "}, {"type": "b", "children": [{"type": "t", "text": "Expression of estrogen induced gene 121-like (EIG121L) during early Xenopus development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene Expr Patterns (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.modgep.2007.03.004"}], "href": "https://doi.org/10.1016/j.modgep.2007.03.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17475571"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17475571"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tetsuro Araki, Morioh Kusakabe, Eisuke Nishida "}, {"type": "b", "children": [{"type": "t", "text": "A transmembrane protein EIG121L is required for epidermal differentiation during early embryonic development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.177907"}], "href": "https://doi.org/10.1074/jbc.M110.177907"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21177533"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21177533"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Qiang Wang, Wenjuan Chang, Xiaohong Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Levels of miR-31 and its target genes in dermal mesenchymal cells of patients with psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Dermatol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/ijd.14197"}], "href": "https://doi.org/10.1111/ijd.14197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30198149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30198149"}]}]}]}
|
| NCBI Gene ID | 222223 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ELAPOR2 has 1,484 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 20 datasets.
Click the + buttons to view associations for ELAPOR2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ELAPOR2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ELAPOR2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ELAPOR2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ELAPOR2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by ELAPOR2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of ELAPOR2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of ELAPOR2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ELAPOR2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ELAPOR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of ELAPOR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ELAPOR2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of ELAPOR2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ELAPOR2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ELAPOR2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ELAPOR2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of ELAPOR2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of ELAPOR2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ELAPOR2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ELAPOR2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ELAPOR2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |